Atıf İçin Kopyala
Tas F., Karabulut S., Ciftci R., Sen F., Sakar B., Disci R., ...Daha Fazla
CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.73, sa.6, ss.1163-1171, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
73
Sayı:
6
-
Basım Tarihi:
2014
-
Doi Numarası:
10.1007/s00280-014-2450-8
-
Dergi Adı:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1163-1171
-
Anahtar Kelimeler:
LDH, CEA, CA19-9, Metastatic, Pancreatic cancer
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Serum LDH, CEA, and CA19-9 levels are important tumor markers in pancreatic cancer. The purpose of this study was to evaluate the clinical significance of serum LDH, CEA, and CA19-9 levels in metastatic pancreatic cancer (MPC) receiving gemcitabine-based chemotherapy.